Startup Spotlight

Startup's next-gen platform cultivates customised microalgae on demand

By Nikki Hancocks contact

- Last updated on GMT

Yemoja
Yemoja

Related tags: Startup company, microalgae

A marine ingredient start-up is tapping into the 'immense potential of marine supercrops’ with its next-gen platform for cultivating customised, pharmaceutical grade microalgae on demand.

Israel-based Yemoja​ was founded three years ago by a team of marine biology and biotech experts with a shared vision of using high-precision fast-track photobioreactor technology to create a prodigious range of high-value microalgae species that can be tailored to a range of applications, including cosmeceuticals and nutraceuticals.

Yemoja cultivated microalgae can be tailored to desired nutritional compounds and functionalities. The startup can produce algae-centered ingredients standardised to any bioactive compound or algae extract encompassing fucoxanthins​, polysaccharides, xanthophylls​, carotenoids, enzymes, and more.

Eyal Shalmon, CEO of Yemoja, says: “There is a vast ocean of microalgae species not yet discovered, and only a dozen or so are commercially available.

“The market is still in the early stages of tapping into the immense potential of these marine ‘supercrops’. Our mission is to boost the entire microalgae value chain with new varieties and yields, and bring them to the mainstream of high-end nutraceutical food and cosmeceutical spheres with additional formulations in the pipeline.”

Erez Ashkenazi COO and co-founder of Yemoja, adds: “Yemoja’s patented technology evolved from a deep-rooted appreciation of biopharma and marine sciences, supported by extensive experience in algae cultivation.

“This unprecedented capacity was collectively harnessed to produce a variety of pure algae at any scale, and in a short time — something the microalgae market has not witnessed until now.”

Yemoja’s intensive cultivation methodology overcomes many of the industry’s hurdles, specifically compositional homogeneity, scalability, and contamination proofing, ensuring clean, safe microalgae throughout the process.

The startup operates an indoor, high-precision, contaminant-free closed cultivation system that maintains absolute control of key parameters such as temperature, pH, light, and CO2​ emissions, and allows for the simultaneous growth of multiple species in a very tightly controlled environment.

This ensures consistent supply of highly standardised specialty ingredients and offers new capabilities to meet the specific needs of suppliers.

The team has already raised US$4 million in seed funds and investments from the Israel Innovation Authority and is currently moving into Round B funding.

Sustainability

Amikam Bar-Gil, CTO and co-founder of Yemoja, explains that part of the startup's vision is to change the algae-based industry towards full sustainability.

Their facility preserves natural resources and recycles every drop of water back into the production process and the extraction process is done without gas or fume emissions. 

“Microalgae are sunlight-driven, single-celled factories, and by nature highly resilient and versatile," ​explains Bar-Gil.

“They also are a powerful source of natural, vegan, bioactive ingredients. Our innovative approach serves to create pure, sustainable microalgae-derived products of the highest quality, and that can be naturally adapted into any desired matrix.”

Health benefits

Microalgae is often utilised within nutraceuticals for its anti-bacterial and anti-inflammatory characters can be useful for several therapeutic methods.

The plant contains various nutritious and bio-active compounds​ ​capable of preventing or curing various acute and chronic diseases.

It is also the only true vegetarian source of EPA and/or DHA omega-3 (people sometimes get confused by flax, chia, etc. which are a source of ALA). 

This powerful plant has also been studied for its potential ability to reduce the symptoms of IBS​.

Related news

Related products

show more

Reach Consumers with Fruit & Vegetable Powders

Reach Consumers with Fruit & Vegetable Powders

vaneeghen | 08-Sep-2021 | Technical / White Paper

Are you looking to create products that appeal to today’s plant-forward consumers? The plant-based revolution continues to captivate the market as consumers...

Turmacin®: Clean Label & Clinically Tested Turmeric

Turmacin®: Clean Label & Clinically Tested Turmeric

Natural Remedies Private Limited | 01-Sep-2021 | Product Presentation

Turmacin® is a clean label project-certified, clinically tested, and clinically safe turmeric extract. Turmacin® is rich in Turmerosaccharides® and doesn't...

How to Enter UK’s £690M CBD Market

How to Enter UK’s £690M CBD Market

The Association for the Cannabinoid Industry | 18-Jun-2021 | Technical / White Paper

The UK has the world’s most developed regulatory framework for legal cannabinoids, such as CBD and CBG. With a 2021 market estimated to be worth £690 million...

Your bioavailable and soluble anti-aging curcumin

Your bioavailable and soluble anti-aging curcumin

Lipofoods, a Lubrizol Company | 11-Jun-2021 | Technical / White Paper

Curcumin´s antioxidant and anti-inflammatory potential is limited by its poor solubility and its low bioavailability. In this respect, Lubrizol microencapsulated...

Related suppliers

Follow us

Products

View more

Webinars